Bristol-Myers Squibb/American Healthcare Systems
This article was originally published in The Tan Sheet
Executive Summary
Nation's largest alliance of not-for-profit health care systems signs five-year purchasing agreement with BMS that will "significantly expand" purchase of BMS products by AmHS. The deal covers BMS U.S. Pharmaceutical Group products, Mead Johnson nutritionals and enteral nutritionals, and devices; the deal does not cover OTCs. The contract, which goes into effect Sept. 1, has a potential "multibillion" dollar value over its five-year life, BMS said Aug. 12.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning